Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
Multiple sclerosis: Reactivation of Epstein-Barr or herpes viruses not associated with MS relapse.
Diagnosing MS: recognizing common symptoms and interpreting MRI results.
Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome.
Neuromyelitis optica pathology in rats following intraperitoneal injection of NMO-IgG and intracerebral needle injury.
Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood.
Disturbance of respiratory muscle control in a patient with early-stage multiple sclerosis.
A modality-agnostic patch-based technique for lesion filling in multiple sclerosis.
Neurology issues in schizophrenia.
Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.
Medical Tourism for CCSVI Procedures in People with Multiple Sclerosis: An Observational Study.
Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
A role for HLA-DRB1*1101 and DRB1*0801 in cognitive ability and its decline with age.
Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses.
Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.
RNA processing-associated molecular mechanisms of neurodegenerative diseases.
T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
Correction: Imatinib Ameliorates Neuroinflammation in a Rat Model of Multiple Sclerosis by Enhancing Blood-Brain Barrier Integrity and by Modulating the Peripheral Immune Response.
Psychiatric diagnoses and cognitive impairment in pediatric multiple sclerosis.
Re. 'Doppler Ultrasound Examination of Multiple Sclerosis Patients and Control Participants: Inter-observer Agreement and Association with Disease'
Effects of vaccination with altered Peptide ligand on chronic pain in experimental autoimmune encephalomyelitis, an animal model of multiple sclerosis.
Pseudobulbar affect: prevalence and management.
Progressive multiple sclerosis does not associate with rs996343 and rs2046748.
Pages
« first
‹ previous
…
579
580
581
582
583
584
585
586
587
…
next ›
last »